FDA NDC Directory · JSON-LD · Markdown

Prochlorperazine

NDC 0713-0135 · HUMAN PRESCRIPTION DRUG · SUPPOSITORY

Labeler / ManufacturerCosette Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA040058
Dosage form / routeSUPPOSITORY · RECTAL
Active ingredientsPROCHLORPERAZINE (25 mg/1)
Marketing started19931130
Package count2

External sources

Source: openFDA. Public-domain (CC0).